Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3287-3301

  Hoorelbeke, Bart ^a   Huskens, Dana ^a   Férir, Geoffrey ^a   François, Katrien O ^a   Takahashi, Atsushi ^b   Van Laethem, Kristel ^a   Schols, Dominique ^a   Tanaka, Haruo ^b   Balzarini, Jan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b IWAKI MEISEI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOHIVIN; CHEMOKINE; GLYCAN; GLYCOPROTEIN GP 120; INTERCELLULAR ADHESION MOLECULE 3; LECTIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIORITY JOURNAL; RAJI CELL; SEQUENCE ALIGNMENT; SIMIAN IMMUNODEFICIENCY VIRUS; SURFACE PLASMON RESONANCE; VIRUS ENTRY; VIRUS NEUTRALIZATION;

ANIMALS; ANTI-HIV AGENTS; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LECTINS; LEUKOCYTES, MONONUCLEAR; MANNOSE; NEUTRALIZATION TESTS; POLYSACCHARIDES;

EID: 77955365315     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00254-10     Document Type: Article

References (49)

1. Balzarini, J., S. Hatse, K. Vermeire, K. Princen, S. Aquaro, C. F. Perno, E. De Clercq, H. Egberink, G. Vanden Mooter, W. Peumans, E. Van Damme, and D. Schols. 2004. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Antimicrob. Agents Chemother. 48:3858-3870.
2. Balzarini, J., K. Van Laethem, W. J. Peumans, E. J. Van Damme, A. Bolmstedt, F. Gago, and D. Schols. 2006. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes. J. Virol. 80:8411-8421. (Pubitemid 44384854)
3. Balzarini, J., K. Van Laethem, S. Hatse, K. Vermeire, E. De Clercq, W. Peumans, E. Van Damme, A.-M. Vandamme, A. Bolmstedt, and D. Schols. 2004. Profile of resistance of human immunodeficiency virus to mannosespecific plant lectins. J. Virol. 78:10617-10627.
4. Balzarini, J., K. Van Laethem, D. Daelemans, S. Hatse, A. Bugatti, M. Rusnati, Y. Igarashi, T. Oki, and D. Schols. 2007. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. J. Virol. 81:362-373. (Pubitemid 44975175)
5. Balzarini, J. 2007. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat. Rev. Microbiol. 5:583-597.
6. Balzarini, J., Y. Van Herrewege, K. Vermeire, G. Vanham, and D. Schols. 2007. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T-lymphocytes. Mol. Pharmacol. 71:3-11.
7. Balzarini, J., K. François, K. Van Laethem, B. Hoorelbeke, M. Renders, J. Auwerx, S. Liekens, T. Oki, Y. Igarashi, and D. Schols. 2010. Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use. Antimicrob. Agents Chemother. 54:1425-1435.
8. Bewley, C. A., K. R. Gustafson, M. R. Boyd, D. G. Covell, A. Bax, G. M. Clore, and A. M. Gronenborn. 1998. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat. Struct. Biol. 5:571-578.
9. Bewley, C. A. 2001. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure 9:931-940.
10. Botos, I., B. R. O'Keefe, S. R. Shenoy, L. K. Cartner, D. M. Ratner, P. H. Seeberger, M. R. Boyd, and A. Wlodawer. 2002. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J. Biol. Chem. 277:34336-34342.
11. Boyd, M. R., K. R. Gustafson, J. B. McMahon, R. H. Shoemaker, B. R. O'Keefe, T. Mori, R. J. Gulakowski, L. Wu, M. I. Rivera, C. M. Laurencot, M. J. Currens, J. H. Cardellina II, R. W. Buckheit, Jr., P. L. Nara, L. K. Pannell, R. C. Sowder II, and L. E. Henderson. 1997. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41:521-530.
12. Chen, B., E. M. Vogan, H. Gong, J. J. Skehel, D. C. Wiley, and S. C. Harrison. 2005. Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein. Structure 13:197-211. (Pubitemid 40247697)
13. Chen, X., M. Lu, B. K. Poon, Q. Wang, and J. Ma. 2009. Structural improvement of unliganded simian immunodeficiency virus gp120 core by normalmode-based X-ray crystallographic refinement. Acta Crystallogr. D Biol. Crystallogr. 65:339-347.
14. Chiba, H., J. Inokoshi, M. Okamoto, S. Asanuma, K. Matsuzaki, M. Iwama, K. Mizumoto, H. Tanaka, M. Oheda, K. Fujita, H. Nakashima, M. Shinose, Y. Takahashi, and S. Omura. 2001. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities. Biochem. Biophys. Res. Commun. 282: 595-601.
15. Chiba, H., J. Inokoshi, H. Nakashima, S. Omura, and H. Tanaka. 2004. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120. Biochem. Biophys. Res. Commun. 316:203-213.
16. Chiba, H., S. Asanuma, M. Okamoto, J. Inokoshi, H. Tanaka, K. Fujita, and S. Omura. 2001. A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines - establishment and validation. J. Antibiot. 54:818-826. (Pubitemid 33049159)
17. Doms, R. W. 2000. Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 276:229-237.
18. Douglas, N. W., G. H. Munro, and R. S. Daniels. 1997. HIV/SIV glycoproteins: structure-function relationships. J. Mol. Biol. 273:122-149.
19. Forsman, A., E. Beirnaert, M. M. Aasa-Chapman, B. Hoorelbeke, K. Hijazi, W. Koh, V. Tack, A. Szynol, C. Kelly, A. McKnight, T. Verrips, H. de Haard, and R. A. Weiss. 2008. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J. Virol. 82:12069-12081.
20. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-585.
21. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. Kewal Ramani, D. R. Littman, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
22. Geyer, H., C. Holschbach, G. Hunsmann, and J. Schneider. 1988. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 263:11760-11767.
23. Grant, R. M., D. Hamer, T. Hope, R. Johnston, J. Lange, M. M. Lederman, J. Lieberman, C. J. Miller, J. P. Moore, D. E. Mosier, D. D. Richman, R.T. Schooley, M. S. Springer, R. S. Veazey, and M. A. Wainberg. 2008. Whither or wither microbicides? Science 321:532-534.
24. Hu, Q., N. Mahmood, and R. J. Shattock. 2007. High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization. Virology 368:145-154. (Pubitemid 47599570)
25. Huskens, D., K. Van Laethem, K. Vermeire, J. Balzarini, and D. Schols. 2007. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. Virology 360:294-304. (Pubitemid 46482610)
26. Huskens, D., K. Vermeire, E. Vandemeulebroucke, J. Balzarini, and D. Schols. 2008. Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent. Int. J. Biochem. Cell Biol. 40:2802-2814.
27. Inokoshi, J., H. Chiba, S. Asanuma, A. Takahashi, S. Omura, and H. Tanaka. 2001. Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli. Biochem. Biophys. Res. Commun. 281:1261-1265.
28. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
29. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
30. Reference deleted.
31. Luallen, R. J., C. Agrawal-Gamse, H. Fu, D. F. Smith, R. W. Doms, and Y. Geng. 2010. Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains. Glycobiology 20:280-286.
32. Princen, K., S. Hatse, K. Vermeire, E. De Clercq, and D. Schols. 2004. Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists. Retrovirology 1:2.
33. Reitter, J. N., and R. C. Desrosiers. 1998. Identification of replicationcompetent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein. J. Virol. 72:5399-5407.
34. Sanders, R. W., M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K. O. Lloyd, P. D. Kwong, and J. P. Moore. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
35. Scanlan, C. N., R. Pantophlet, M. R. Wormald, S. E. Ollmann, R. Stanfield, I. A. Wilson, H. Katinger, R. A. Dwek, P. M. Rudd, and D. R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α(1-2) mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
36. Scanlan, C. N., J. Offer, N. Zitzmann, and R. A. Dwek. 2007. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446:1038-1045.
37. Shattock, R. J., and R. W. Doms. 2002. AIDS models: microbicides could learn from vaccines. Nat. Med. 8:425.
38. Shattock, R. J., and J. P. Moore. 2003. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1:25-34.
39. Shibuya, N., I. J. Goldstein, J. A. Shafer, W. J. Peumans, and W. F. Broekaert. 1986. Carbohydrate binding properties of the stinging nettle (Urtica dioica) rhizome lectin. Arch. Biochem. Biophys. 249:215-224.
40. Takahashi, A., J. Inokoshi, H. Chiba, S. Omura, and H. Tanaka. 2005. Essential regions for antiviral activities of actinohivin, a sugar-binding antihuman immunodeficiency virus protein from an actinomycete. Arch. Biochem. Biophys. 437:233-240.
41. Tanaka, H., H. Chiba, J. Inokoshi, A. Kuno, T. Sugai, A. Takahashi, Y. Ito, M. Tsunoda, K. Suzuki, A. Takénaka, T. Sekiguchi, H. Umeyama, J. Hirabayashi, and S. Omura. 2009. Mechanism by which the lectin actinohivin blocks HIV infection of target cells. Proc. Natl. Acad. Sci. U. S. A. 106:15633-15638.
42. Trkola, A., M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J. P. Moore, and H. Katinger. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70: 1100-1108.
43. Tsai, C. C., P. Emau, Y. Jiang, B. Tian, W. R. Morton, K. R. Gustafson, and M. R. Boyd. 2003. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retrovir. 19:535-541.
44. Tsai, C. C., P. Emau, Y. Jiang, M. B. Agy, R. J. Shattock, A. Schmidt, W. R. Morton, K. R. Gustafson, and M. R. Boyd. 2004. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retrovir. 20:11-18.
45. Überla, K., C. Stahl-Hennig, D. Böttiger, K. Mätz-Rensing, F. J. Kaup, J. Li, W. A. Haseltine, B. Fleckenstein, G. Hunsmann, B. Öberg, and J. Sodroski. 1995. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 92:8210-8214.
46. Van Damme, E. J. M., A. K. Allen, and W. J. Peumans. 1988. Related mannose-specific lectins from different species of the family Amaryllidaceae. Physiol. Plant 73:52-57.
47. Van Laethem, K., Y. Schrooten, P. Lemey, E. Van Wijngaerden, S. De Wit, M. Van Ranst, and A. M. A. Vandamme. 2005. Genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. J. Virol. Methods 123:25-34. (Pubitemid 39593730)
48. Witvrouw, M., V. Fikkert, A. Hantson, C. Pannecouque, B. R. O'Keefe, J. McMahon, L. Stamatatos, E. De Clercq, and A. Bolmstedt. 2005. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J. Virol. 79:7777-7784. (Pubitemid 40756811)
49. Yang, F., C. A. Bewley, J. M. Louis, K. R. Gustafson, M. R. Boyd, A. M. Gronenborn, G. M. Clore, and A. Wlodawer. 1999. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J. Mol. Biol. 288:403-412.